CD163 and gastric cancer: In the study cohort of 126 GC patients, 65 (51.6%) had high expression of CD4+ TILs, 24 (19.0%) had high expression of CD8+TILs, and 51 (40.5%) had high expression of CD163+ TAMs (Table 1).